Production of delayed drug release particles in the body

摘要

In situ production of particles (I) involves preparing a mixture of a fluid carrier phase (CP) and a second phase (SP), introducing the mixture into a living body and forming (I). (I) preferably contain an active agent (A). Also claimed are preparations (specifically for oral administration (especially as a capsule) or for parenteral administration) and particles (I) obtained by the process.